Exclusive: Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says
FILE PHOTO: The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company’s 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File PhotoJERUSALEM (Reuters) – Israel’s Teva Pharmaceutical Industries is in talks…
Read MoreDrug trial that could improve respiratory recovery from COVID-19 now underway
A clinical trial has commenced this week to test whether a drug called Almitrine can help people who are seriously ill with COVID-19 to recover from the disease. Patients suffering from COVID-19 pneumonia often develop very low levels of oxygen,…
Read MoreBuild Serious Midback Strength With This Incline Row Finisher
The classic incline row is a key exercise for midback strength. But what if you could use it to attack your rear delts too? Truth be told, your rear delts are involved in incline rows (and all row exercises) anyway….
Read MoreMissed medications aren’t reason for greater risk of clots in patients with COVID-19
According to recent research studies, patients hospitalized with COVID-19 are at high risk of developing venous thromboembolism (VTE), a potentially deadly condition in which a blood clot forms in the deep veins of the leg, groin or arm (known as…
Read MoreRabies treatment demonstrated as safe and effective for use in children in first pediatric trial
A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under. Results published today in Human Vaccines & Immunotherapeutics report the…
Read MoreFDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the first immunotherapy treatment indicated for patients with…
Read MoreModified CRISPR/Cas9 complex targets specific histones
Finding a needle in a haystack is hard enough. But try finding a specific molecule on the needle. Rice University researchers have achieved something of the sort with a new genome editing tool that targets the supporting players in a…
Read MorePeople with dementia found to have significantly increased risk for COVID-19
A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19-;and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults…
Read MoreResearchers broaden tracking of COVID-19 through wastewater
Although it is still challenging to prevent the transmission of COVID-19, researchers at the University of Miami are using all the strategies they can to fend off the spread. That includes using cutting-edge research to detect SARS-CoV-2—the virus that causes…
Read More62.9 million doses of COVID-19 vaccines delivered, 43.2 million administered: U.S. CDC
FILE PHOTO: Registered pharmacist fills a dead volume syringe with the COVID-19 vaccine at a pop-up vaccination site in William Reid Apartments in Brooklyn, New York City, U.S., January 23, 2021. Mary Altaffer/Pool via REUTERS(Reuters) – The U.S. Centers for…
Read More